Neo Ivy Capital Management Jazz Pharmaceuticals PLC Transaction History

Neo Ivy Capital Management

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 15, 2023	BUY	$122.5 - $147.16 $473,707 - $569,067	3,867 New	3,867 $479,000
Q3 2022 Nov 15, 2022	BUY	$126.59 - $161.18 $204,949 - $260,950	1,619 New	1,619 $216,000
Q2 2021 Aug 16, 2021	SELL	$160.2 - $186.42 $249,271 - $290,069	-1,556 Closed	0 $0
Q1 2021 Oct 07, 2021	BUY	$150.19 - $173.5 $233,695 - $269,966	1,556 New	1,556 $256,000
Q1 2019 May 15, 2019	SELL	$121.81 - $142.95 $880,686 - $1.03 Million	-7,230 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$115.94 - $166.74 $838,246 - $1.21 Million	7,230 New	7,230 $896,000

512

57.5M

188K

133K

Ticker JAZZ
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,680,700
Market Cap $7.71B
Description
Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...

Get notified when there are updates to the investment portfolio of Neo Ivy Capital Management, based on Form 13F filings with the SEC.

Stay updated on Neo Ivy Capital Management with notifications on news.